New stroke drug shows promise in early safety trial
NCT ID NCT00821821
First seen Jan 10, 2026 · Last updated Apr 30, 2026 · Updated 12 times
Summary
This study tested a drug called MCI-186 in 36 adults who had an acute ischemic stroke (a stroke caused by a blood clot). The main goal was to see if the drug is safe and how the body processes it. Participants received either the drug or a placebo within 1 to 24 hours after their symptoms started. The study did not aim to cure the stroke, but to gather safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE AIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erasmus Medical Center
Rotterdam, Netherlands
-
Helsinki University Central Hospital
Helsinki, Finland
-
Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle, United Kingdom
Conditions
Explore the condition pages connected to this study.